Nguyen Ha Thi, Le Do Thanh, Duong Quan Hong, Tatipamula Vinay Bharadwaj, Van Nguyen Bang
Institute of Research and Development, Duy Tan University, Danang 550000, Vietnam.
Faculty of Medicine, Duy Tan University, Danang 550000, Vietnam.
Oncol Lett. 2021 Jan;21(1):41. doi: 10.3892/ol.2020.12302. Epub 2020 Nov 13.
Tumor heterogeneity and resistance to chemotherapy have been recognized as two major obstacles in the diagnosis and treatment of colorectal cancer (CRC). Microsatellite instability (MSI) and and mutations are common diagnostic factors that have been widely used to classify CRC for therapeutics. In the present study, 151 patients with CRC were analyzed from the two most populous ethnic groups of Vietnam, Kinh and Muong, for their MSI status, frequency of and mutations, and their clinical implications. MSI-high (MSI-H) was detected in 45.0% (68/151), while mutated and were identified in 37.1% (56/151) and 2.6% (4/151) of the cases, respectively. There was a substantial co-existence of MSI-H with (27/56; 48.2%) and (3/4; 75.0%) mutations. Statistical analysis showed that MSI-H tumors were significantly associated with colon location (P=0.011) and more advanced T stages (P=0.016). exon 2 mutations were significantly more likely to be detected in patients who belonged to the Muong ethnic group (P=0.013) or those with no/fewer lymph node metastasis (P=0.048) as compared with their counterparts. In summary, the data revealed typical molecular features of Vietnamese patients with CRC, including a strikingly high rate of MSI-H and its high co-existence with and mutations, which should be carefully considered in the future therapeutics for this type of cancer.
肿瘤异质性和对化疗的耐药性已被公认为是结直肠癌(CRC)诊断和治疗中的两大主要障碍。微卫星不稳定性(MSI)以及 和 突变是常见的诊断因素,已被广泛用于对CRC进行治疗分类。在本研究中,对越南人口最多的两个民族京族和芒族的151例CRC患者进行了分析,以了解他们的MSI状态、 和 突变频率及其临床意义。在45.0%(68/151)的患者中检测到高微卫星不稳定性(MSI-H),而分别在37.1%(56/151)和2.6%(4/151)的病例中发现了 和 突变。MSI-H与 (27/56;48.2%)和 (3/4;75.0%)突变大量共存。统计分析表明,MSI-H肿瘤与结肠部位(P = 0.011)和更晚期的T分期(P = 0.016)显著相关。与相应人群相比,芒族患者(P = 0.013)或无/较少淋巴结转移的患者(P = 0.048)中 外显子2突变的检测可能性显著更高。总之,数据揭示了越南CRC患者的典型分子特征,包括MSI-H的惊人高发生率及其与 和 突变的高共存率,在未来针对这类癌症的治疗中应仔细考虑这些特征。